Pfs230D1M-EPA/AS01 Vaccine, a Transmission Blocking Vaccine Against Plasmodium Falciparum, in an Age De-Escalation Trial of Children and a Family Compound Trial in Mali
PHASE2
Background:
Malaria affects many people in Mali and other parts of Africa....
Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali
PHASE1
Background:
\- Malaria is a severe infection caused by a parasite. People ...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali
PHASE1
Background:
Researchers are looking for new ways to control and eradicate ...